What to Expect at Immuno-Oncology 360° 2018
Immuno-Oncology 360° is a comprehensive program providing exposure to the entire spectrum of R&D, addressing key aspects from all facets of IO including: Discovery / Preclinical ScienceTranslational S...
20 Syys 20177min
Why Pharma R&D has to Start Thinking Like a Service Industry and How?
The Conference Forum is pleased to share a podcast featuring keynote speaker and world renowned customer service expert, Dr Chip Bell who spoke at the 6th annual DPharm: Disruptive Innovations to Adva...
24 Elo 201748min
The Gap Between Clinical Care, Patient Involvement & What Patients Want
Originally recorded during the 4th annual Patients as Partners US event held in Philadelphia, March 2017, Bristol-Myers Squibb’s Mary Stober-Murray moderates this multi-stakeholder panel to discuss wh...
27 Kesä 201752min
Digital Solutions Impacting the Economic Efficacy of Clinical Trials
Internationally recognized digital health expert, Donald Jones, MBA, Chief Digital Officer at Scripps Translational Science Institute, shares his insights on the digital clinical trial landscape and t...
26 Kesä 201745min
Partnering with Patient Organizations for Advancing Cures
In this multi-stakeholder session from the 4th annual Patients as Partners US meeting, patients, advocates, industry and nonprofit organizations come together to discuss how they partnered and the out...
23 Kesä 201742min
Challenges and Opportunities in Pursuing a New Therapeutic Modality
Adapted from the 2016 Chief Medical Officer Summit keynote address, Dr Akshay Vaishnaw, who serves as EVP of R&D and CMO at Alnylam Pharmaceuticals, tackles the challenges and opportunities in pursuin...
23 Kesä 201737min
Partnering with Patients in the Development and Lifecycle of Medicines
At the 2017 Partners Europe event in London, Nicholas Brooke, Chief Executive, Patient Focused Medicines Development (PFMD) and Jan Geissler, Director, European Patients’ Academy on Therapeutic Innova...
22 Kesä 201737min
Trends and Collaborations in the IO Space
Dr Axel Hoos, GSK, leads a panel discussion on Trends and Collaborations in the Immuno-Oncology Space, featuring Dr Ramy Ibrahim, VP and Head of R&D, Parker Institute for Cancer Immunotherapy; Dr Jill...
22 Kesä 201742min
